Cerebrospinal Fluid Bacillary Load by Xpert MTB/RIF Ultra Polymerase Chain Reaction Cycle Threshold Value Predicts 2-Week Mortality in Human Immunodeficiency Virus–Associated Tuberculous Meningitis
Abstract Background The World Health Organization recommends GeneXpert MTB/RIF Ultra (Xpert Ultra), a fully automated polymerase chain reaction (PCR) assay, as the initial tuberculous meningitis (TBM) diagnostic test. The assay’s PCR cycle threshold (Ct) values represent the number of PCR cycles req...
Saved in:
Published in | Clinical infectious diseases Vol. 73; no. 9; pp. e3505 - e3510 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
US
Oxford University Press
02.11.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Background
The World Health Organization recommends GeneXpert MTB/RIF Ultra (Xpert Ultra), a fully automated polymerase chain reaction (PCR) assay, as the initial tuberculous meningitis (TBM) diagnostic test. The assay’s PCR cycle threshold (Ct) values represent the number of PCR cycles required for probe signal to be detected (low Ct value = high bacillary load) and may approximate tuberculosis (TB) bacillary load. We measured the relationship between cerebrospinal fluid (CSF) TB bacillary load with mortality.
Methods
We prospectively enrolled 102 human immunodeficiency virus (HIV)–positive Ugandans with probable or definite TBM from April 2015 to August 2019. Xpert Ultra Ct tertiles and semi-quantitative categories were separately analyzed as predictors of 2-week mortality. We investigated associations between Ct and baseline clinical and CSF parameters.
Results
Subjects with Ct values in the low tertile (ie, high bacillary load) had 57% 2-week mortality—worse than the intermediate (17%) and high (25%) Ct tertiles and Xpert Ultra–negative (30%) probable TBM cases (P = .01). In contrast, the reported semi-quantitative Xpert Ultra categorization was less precise; with the medium to low category trending toward worse 2-week survival (42%) compared with very low (28%), trace (26%), and negative (30%) categories (P = .48). Ct tertile was significantly associated with baseline CSF lactate (P = .03).
Conclusions
High CSF TB bacillary load, as measured by Xpert Ultra Ct tertile, is associated with an almost 2-fold higher 2-week mortality in HIV-associated TBM and is a better predictor than the reported Xpert Ultra semi-quantitative category. Xpert Ultra Ct values could identify TBM patients at increased risk of death who may benefit from enhanced supportive care.
High cerebrospinal fluid (CSF) tuberculosis bacillary load, as measured by GeneXpert Ultra cycle threshold tertile, is associated with an almost 2-fold higher 2-week mortality in HIV-associated tuberculosis meningitis and may be a better predictor of outcome than the reported Xpert Ultra semi-quantitative category. |
---|---|
AbstractList | The World Health Organization recommends GeneXpert MTB/RIF Ultra (Xpert Ultra), a fully automated polymerase chain reaction (PCR) assay, as the initial tuberculous meningitis (TBM) diagnostic test. The assay's PCR cycle threshold (Ct) values represent the number of PCR cycles required for probe signal to be detected (low Ct value = high bacillary load) and may approximate tuberculosis (TB) bacillary load. We measured the relationship between cerebrospinal fluid (CSF) TB bacillary load with mortality.BACKGROUNDThe World Health Organization recommends GeneXpert MTB/RIF Ultra (Xpert Ultra), a fully automated polymerase chain reaction (PCR) assay, as the initial tuberculous meningitis (TBM) diagnostic test. The assay's PCR cycle threshold (Ct) values represent the number of PCR cycles required for probe signal to be detected (low Ct value = high bacillary load) and may approximate tuberculosis (TB) bacillary load. We measured the relationship between cerebrospinal fluid (CSF) TB bacillary load with mortality.We prospectively enrolled 102 human immunodeficiency virus (HIV)-positive Ugandans with probable or definite TBM from April 2015 to August 2019. Xpert Ultra Ct tertiles and semi-quantitative categories were separately analyzed as predictors of 2-week mortality. We investigated associations between Ct and baseline clinical and CSF parameters.METHODSWe prospectively enrolled 102 human immunodeficiency virus (HIV)-positive Ugandans with probable or definite TBM from April 2015 to August 2019. Xpert Ultra Ct tertiles and semi-quantitative categories were separately analyzed as predictors of 2-week mortality. We investigated associations between Ct and baseline clinical and CSF parameters.Subjects with Ct values in the low tertile (ie, high bacillary load) had 57% 2-week mortality-worse than the intermediate (17%) and high (25%) Ct tertiles and Xpert Ultra-negative (30%) probable TBM cases (P = .01). In contrast, the reported semi-quantitative Xpert Ultra categorization was less precise; with the medium to low category trending toward worse 2-week survival (42%) compared with very low (28%), trace (26%), and negative (30%) categories (P = .48). Ct tertile was significantly associated with baseline CSF lactate (P = .03).RESULTSSubjects with Ct values in the low tertile (ie, high bacillary load) had 57% 2-week mortality-worse than the intermediate (17%) and high (25%) Ct tertiles and Xpert Ultra-negative (30%) probable TBM cases (P = .01). In contrast, the reported semi-quantitative Xpert Ultra categorization was less precise; with the medium to low category trending toward worse 2-week survival (42%) compared with very low (28%), trace (26%), and negative (30%) categories (P = .48). Ct tertile was significantly associated with baseline CSF lactate (P = .03).High CSF TB bacillary load, as measured by Xpert Ultra Ct tertile, is associated with an almost 2-fold higher 2-week mortality in HIV-associated TBM and is a better predictor than the reported Xpert Ultra semi-quantitative category. Xpert Ultra Ct values could identify TBM patients at increased risk of death who may benefit from enhanced supportive care.CONCLUSIONSHigh CSF TB bacillary load, as measured by Xpert Ultra Ct tertile, is associated with an almost 2-fold higher 2-week mortality in HIV-associated TBM and is a better predictor than the reported Xpert Ultra semi-quantitative category. Xpert Ultra Ct values could identify TBM patients at increased risk of death who may benefit from enhanced supportive care. Abstract Background The World Health Organization recommends GeneXpert MTB/RIF Ultra (Xpert Ultra), a fully automated polymerase chain reaction (PCR) assay, as the initial tuberculous meningitis (TBM) diagnostic test. The assay’s PCR cycle threshold (Ct) values represent the number of PCR cycles required for probe signal to be detected (low Ct value = high bacillary load) and may approximate tuberculosis (TB) bacillary load. We measured the relationship between cerebrospinal fluid (CSF) TB bacillary load with mortality. Methods We prospectively enrolled 102 human immunodeficiency virus (HIV)–positive Ugandans with probable or definite TBM from April 2015 to August 2019. Xpert Ultra Ct tertiles and semi-quantitative categories were separately analyzed as predictors of 2-week mortality. We investigated associations between Ct and baseline clinical and CSF parameters. Results Subjects with Ct values in the low tertile (ie, high bacillary load) had 57% 2-week mortality—worse than the intermediate (17%) and high (25%) Ct tertiles and Xpert Ultra–negative (30%) probable TBM cases (P = .01). In contrast, the reported semi-quantitative Xpert Ultra categorization was less precise; with the medium to low category trending toward worse 2-week survival (42%) compared with very low (28%), trace (26%), and negative (30%) categories (P = .48). Ct tertile was significantly associated with baseline CSF lactate (P = .03). Conclusions High CSF TB bacillary load, as measured by Xpert Ultra Ct tertile, is associated with an almost 2-fold higher 2-week mortality in HIV-associated TBM and is a better predictor than the reported Xpert Ultra semi-quantitative category. Xpert Ultra Ct values could identify TBM patients at increased risk of death who may benefit from enhanced supportive care. High cerebrospinal fluid (CSF) tuberculosis bacillary load, as measured by GeneXpert Ultra cycle threshold tertile, is associated with an almost 2-fold higher 2-week mortality in HIV-associated tuberculosis meningitis and may be a better predictor of outcome than the reported Xpert Ultra semi-quantitative category. High cerebrospinal fluid (CSF) tuberculosis bacillary load, as measured by GeneXpert Ultra cycle threshold tertile, is associated with an almost 2-fold higher 2-week mortality in HIV-associated tuberculosis meningitis and may be a better predictor of outcome than the reported Xpert Ultra semi-quantitative category. |
Author | Rutakingirwa, Morris K Bahr, Nathan C Boulware, David R Martyn, Emily M Wadda, Vincent Okirwoth, Michael Pullen, Matthew F Meya, David B Kagimu, Enock Bold, Tyler D Bangdiwala, Ananta S Kasibante, John Stead, Gavin Cresswell, Fiona V |
AuthorAffiliation | 1 Infectious Diseases Institute , Kampala, Uganda 5 University of Kansas Medical Center , Kansas City, Kansas, USA 6 Clinical Research Department, London School of Hygiene and Tropical Medicine , London, United Kingdom 4 Department of Medicine, College of Health Sciences, Makerere University , Kampala, Uganda 2 University of Minnesota , Minneapolis, Minneapolis, USA 3 Mulago National Referral Hospital , Kampala, Uganda |
AuthorAffiliation_xml | – name: 6 Clinical Research Department, London School of Hygiene and Tropical Medicine , London, United Kingdom – name: 4 Department of Medicine, College of Health Sciences, Makerere University , Kampala, Uganda – name: 1 Infectious Diseases Institute , Kampala, Uganda – name: 5 University of Kansas Medical Center , Kansas City, Kansas, USA – name: 3 Mulago National Referral Hospital , Kampala, Uganda – name: 2 University of Minnesota , Minneapolis, Minneapolis, USA |
Author_xml | – sequence: 1 givenname: Emily M orcidid: 0000-0003-4981-9298 surname: Martyn fullname: Martyn, Emily M email: emily.martyn@doctors.org.uk organization: Infectious Diseases Institute, Kampala, Uganda – sequence: 2 givenname: Ananta S surname: Bangdiwala fullname: Bangdiwala, Ananta S organization: University of Minnesota, Minneapolis, Minneapolis, USA – sequence: 3 givenname: Enock surname: Kagimu fullname: Kagimu, Enock organization: Infectious Diseases Institute, Kampala, Uganda – sequence: 4 givenname: Morris K surname: Rutakingirwa fullname: Rutakingirwa, Morris K organization: Infectious Diseases Institute, Kampala, Uganda – sequence: 5 givenname: John surname: Kasibante fullname: Kasibante, John organization: Infectious Diseases Institute, Kampala, Uganda – sequence: 6 givenname: Michael surname: Okirwoth fullname: Okirwoth, Michael organization: Infectious Diseases Institute, Kampala, Uganda – sequence: 7 givenname: Gavin surname: Stead fullname: Stead, Gavin organization: Infectious Diseases Institute, Kampala, Uganda – sequence: 8 givenname: Vincent surname: Wadda fullname: Wadda, Vincent organization: Mulago National Referral Hospital, Kampala, Uganda – sequence: 9 givenname: Matthew F surname: Pullen fullname: Pullen, Matthew F organization: University of Minnesota, Minneapolis, Minneapolis, USA – sequence: 10 givenname: Tyler D surname: Bold fullname: Bold, Tyler D organization: University of Minnesota, Minneapolis, Minneapolis, USA – sequence: 11 givenname: David B surname: Meya fullname: Meya, David B organization: Infectious Diseases Institute, Kampala, Uganda – sequence: 12 givenname: David R surname: Boulware fullname: Boulware, David R organization: University of Minnesota, Minneapolis, Minneapolis, USA – sequence: 13 givenname: Nathan C surname: Bahr fullname: Bahr, Nathan C organization: University of Kansas Medical Center, Kansas City, Kansas, USA – sequence: 14 givenname: Fiona V surname: Cresswell fullname: Cresswell, Fiona V organization: Infectious Diseases Institute, Kampala, Uganda |
BookMark | eNp9UctuEzEUtVARbQM7PsA7WDDUHnuSmQ1SG5E2UiKqKi3sRh77TmPw2KkfSLPjH_pR_AdfgqsUJJBgceUr-Zxz7z3nGB1YZwGhl5S8paRhJ1KrXEJQzvkTdEQrNiumVUMPck-quuA1qw_RcQifCaG0JtUzdMjKpp7OmvIIfZ-Dh867sNNWGLwwSSt8JqQ2RvgRr5xQuBvxpx34iNebs5Or5QJfm-gFvnRmHMCLAHi-FdriKxAyamfxfJQG8GbrIWydUfhGmAT40oPSMgZcFh8BvuC181EYHUecuRdpEBYvhyFZp6DXUoOVI77RPoUf3-5PQ3D5yAgKb1IHXibjUsBrsNre6qjDc_S0FybAi8d3gq4X7zfzi2L14Xw5P10VkldNLBRIzio2rVhVzQQtoWuoIIoJIjmXpSS87tS0EZz3VDZNr3pGgdYN7zkVsiNsgt7tdXepG0BJsNkK0-68HrJfrRO6_fPH6m176762dTVlNM-doNePAt7dJQixHXSQkO22kE9qS85nGcgpy9A3e6jM-QQP_e8xlLQP2bc5-_ZX9hle_gWXOoqHQPIi2vyL9GpPcmn3f_mf0r7IMQ |
CitedBy_id | crossref_primary_10_1038_s41598_025_87739_5 crossref_primary_10_4103_apjtm_apjtm_60_24 crossref_primary_10_1016_j_diagmicrobio_2025_116704 crossref_primary_10_1136_thorax_2022_219103 crossref_primary_10_5582_ddt_2022_01082 crossref_primary_10_1016_S1474_4422_21_00435_X crossref_primary_10_1080_14737159_2023_2223980 crossref_primary_10_1080_07853890_2022_2123560 |
Cites_doi | 10.1086/378642 10.1093/infdis/jiy588 10.1016/S1473-3099(10)70138-9 10.1093/infdis/jix051 10.1093/ofid/ofz419 10.1371/journal.pone.0020077 10.1186/1745-6215-12-25 10.1007/s00415-013-7060-6 10.1016/S1473-3099(14)70852-7 10.1097/QAI.0b013e31828e1e56 10.4269/ajtmh.14-0452 10.1016/S1473-3099(19)30550-X 10.1016/S1473-3099(12)70264-5 10.1056/NEJMoa1507062 10.1016/S1473-3099(17)30474-7 10.1016/j.ijid.2018.01.014 10.1016/j.tube.2019.101864 10.1093/infdis/jix050 10.1371/journal.pone.0001772 |
ContentType | Journal Article |
Copyright | The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. 2020 The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. |
Copyright_xml | – notice: The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. 2020 – notice: The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. |
DBID | TOX AAYXX CITATION 7X8 5PM |
DOI | 10.1093/cid/ciaa1444 |
DatabaseName | Oxford Journals Open Access Collection CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: TOX name: Oxford Journals Open Access Collection url: https://academic.oup.com/journals/ sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1537-6591 |
EndPage | e3510 |
ExternalDocumentID | PMC8563165 10_1093_cid_ciaa1444 10.1093/cid/ciaa1444 |
GrantInformation_xml | – fundername: ; – fundername: ; grantid: T32AI055433; R01AI145437 – fundername: ; grantid: R01NS086312; K23NS110470 – fundername: ; grantid: 210772/Z/18/Z |
GroupedDBID | --- ..I .2P .GJ .I3 .ZR 08P 0R~ 1KJ 1TH 29B 2AX 2WC 36B 3O- 4.4 48X 53G 5GY 5RE 5VS 5WD 6J9 70D AABZA AACGO AACZT AAJKP AAJQQ AAMVS AANCE AAOGV AAPGJ AAPNW AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAWDT AAYOK ABBHK ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABNGD ABNHQ ABNKS ABOCM ABPLY ABPQP ABPTD ABQLI ABQNK ABSMQ ABTLG ABVGC ABWST ABXSQ ABXVV ABZBJ ACFRR ACGFO ACGFS ACHIC ACPQN ACPRK ACUFI ACUKT ACUTJ ACUTO ACVCV ACYHN ACZBC ADBBV ADEYI ADGZP ADHKW ADHZD ADIPN ADMTO ADNBA ADOCK ADQBN ADQXQ ADRTK ADULT ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKPW AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEUPB AEWNT AEXZC AFFNX AFFQV AFFZL AFIYH AFOFC AFRAH AFSHK AFXAL AFYAG AGINJ AGKEF AGKRT AGMDO AGQXC AGSYK AGUTN AHMBA AHMMS AHXPO AI. AIAGR AIJHB AJDVS AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APJGH APWMN AQDSO AQKUS AQVQM ASPBG ATGXG AVNTJ AVWKF AXUDD AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM BZKNY C1A C45 CDBKE CS3 CZ4 DAKXR DCCCD DIK DILTD DU5 D~K E3Z EBS EE~ EIHJH EJD EMOBN ENERS F5P F9B FECEO FEDTE FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC H13 H5~ HAR HQ3 HTVGU HVGLF HW0 HZ~ IOX IPSME J21 J5H JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST JXSIZ KAQDR KBUDW KOP KSI KSN L7B M49 MBLQV MHKGH MJL ML0 N4W N9A NGC NOMLY NOYVH NU- NVLIB O0~ O9- OAUYM OAWHX OBFPC OCZFY ODMLO ODZKP OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD RD5 ROX ROZ RUSNO RW1 RXO SA0 SJN TCURE TEORI TJX TMA TOX TR2 VH1 W8F X7H Y6R YAYTL YKOAZ YXANX ZGI ~91 ~S- AAYXX AGORE AHGBF AJBYB CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c459t-dec4353653557a12eb91a0d3a0c44c2c048bd69a44f1c99fdf31e1894f41acb03 |
IEDL.DBID | TOX |
ISSN | 1058-4838 1537-6591 |
IngestDate | Thu Aug 21 18:07:44 EDT 2025 Fri Jul 11 11:41:44 EDT 2025 Thu Apr 24 23:09:07 EDT 2025 Tue Jul 01 01:18:30 EDT 2025 Wed Apr 02 07:13:54 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | TB meningitis tuberculous meningitis GeneXpert Ultra ultra |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c459t-dec4353653557a12eb91a0d3a0c44c2c048bd69a44f1c99fdf31e1894f41acb03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-4981-9298 |
OpenAccessLink | https://dx.doi.org/10.1093/cid/ciaa1444 |
PMID | 32986792 |
PQID | 2447316413 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8563165 proquest_miscellaneous_2447316413 crossref_primary_10_1093_cid_ciaa1444 crossref_citationtrail_10_1093_cid_ciaa1444 oup_primary_10_1093_cid_ciaa1444 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20211102 |
PublicationDateYYYYMMDD | 2021-11-02 |
PublicationDate_xml | – month: 11 year: 2021 text: 20211102 day: 02 |
PublicationDecade | 2020 |
PublicationPlace | US |
PublicationPlace_xml | – name: US |
PublicationTitle | Clinical infectious diseases |
PublicationYear | 2021 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Heemskerk (2021110300161443800_CIT0006) 2016; 374 Durski (2021110300161443800_CIT0005) 2013; 63 Woldeamanuel (2021110300161443800_CIT0003) 2014; 261 Hai (2021110300161443800_CIT0012) 2019; 119 World Health Organization (2021110300161443800_CIT0009) Bahr (2021110300161443800_CIT0010) 2018; 18 Cresswell (2021110300161443800_CIT0008) 2020; 20 Pirofski (2021110300161443800_CIT0019) 2017; 8:e02063-17 van Laarhoven (2021110300161443800_CIT0013) 2017; 215 Marais (2021110300161443800_CIT0015) 2010; 10 Torok (2021110300161443800_CIT0017) 2008; 3 Marais (2021110300161443800_CIT0023) 2011; 6 Heemskerk (2021110300161443800_CIT0021) 2011; 12 World Health Organization (2021110300161443800_CIT0001) 2019 Thuong (2021110300161443800_CIT0016) 2017; 215 Ellis (2021110300161443800_CIT0002) 2019; 6 Cresswell (2021110300161443800_CIT0018) 2018; 68 Thwaites (2021110300161443800_CIT0020) 2003; 188 Ruslami (2021110300161443800_CIT0022) 2013; 13 Rajasingham (2021110300161443800_CIT0004) 2015; 92 Thuong (2021110300161443800_CIT0014) 2019; 219 Chakravorty (2021110300161443800_CIT0011) 2017; 8:e00812-17 Chiang (2021110300161443800_CIT0007) 2014; 14 |
References_xml | – volume: 188 start-page: 1105 year: 2003 ident: 2021110300161443800_CIT0020 article-title: Pathophysiology and prognosis in Vietnamese adults with tuberculous meningitis publication-title: J Infect Dis doi: 10.1086/378642 – volume: 219 start-page: 986 year: 2019 ident: 2021110300161443800_CIT0014 article-title: Pretreatment cerebrospinal fluid bacterial load correlates with inflammatory response and predicts neurological events during tuberculous meningitis treatment publication-title: J Infect Dis doi: 10.1093/infdis/jiy588 – volume: 10 start-page: 803 year: 2010 ident: 2021110300161443800_CIT0015 article-title: Tuberculous meningitis: a uniform case definition for use in clinical research publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(10)70138-9 – volume: 215 start-page: 1029 year: 2017 ident: 2021110300161443800_CIT0013 article-title: Clinical parameters, routine inflammatory markers, and LTA4H genotype as predictors of mortality among 608 patients with tuberculous meningitis in Indonesia publication-title: J Infect Dis doi: 10.1093/infdis/jix051 – volume: 6 start-page: ofz419 year: 2019 ident: 2021110300161443800_CIT0002 article-title: The changing epidemiology of HIV-associated adult meningitis, Uganda 2015–2017 publication-title: Open Forum Infect Dis doi: 10.1093/ofid/ofz419 – volume: 6 start-page: e20077 year: 2011 ident: 2021110300161443800_CIT0023 article-title: Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting publication-title: PLoS One doi: 10.1371/journal.pone.0020077 – volume-title: Global tuberculosis report year: 2019 ident: 2021110300161443800_CIT0001 – volume: 12 start-page: 25 year: 2011 ident: 2021110300161443800_CIT0021 article-title: Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial publication-title: Trials doi: 10.1186/1745-6215-12-25 – volume: 261 start-page: 851 year: 2014 ident: 2021110300161443800_CIT0003 article-title: A 43-year systematic review and meta-analysis: case-fatality and risk of death among adults with tuberculous meningitis in Africa publication-title: J Neurol doi: 10.1007/s00415-013-7060-6 – volume: 14 start-page: 947 year: 2014 ident: 2021110300161443800_CIT0007 article-title: Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(14)70852-7 – volume: 63 start-page: e101 year: 2013 ident: 2021110300161443800_CIT0005 article-title: Cost-effective diagnostic checklists for meningitis in resource-limited settings publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e31828e1e56 – volume: 92 start-page: 274 year: 2015 ident: 2021110300161443800_CIT0004 article-title: Epidemiology of meningitis in an HIV-infected Ugandan cohort publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.14-0452 – volume: 8:e00812-17 year: 2017 ident: 2021110300161443800_CIT0011 article-title: The New Xpert MTB/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing publication-title: mBio – volume: 8:e02063-17 year: 2017 ident: 2021110300161443800_CIT0019 article-title: Immune-mediated damage completes the parabola: Cryptococcus neoformans pathogenesis can reflect the outcome of a weak or strong immune response publication-title: mBio – volume: 20 start-page: 308 year: 2020 ident: 2021110300161443800_CIT0008 article-title: Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(19)30550-X – volume: 13 start-page: 27 year: 2013 ident: 2021110300161443800_CIT0022 article-title: Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(12)70264-5 – volume: 374 start-page: 124 year: 2016 ident: 2021110300161443800_CIT0006 article-title: Intensified antituberculosis therapy in adults with tuberculous meningitis publication-title: N Engl J Med doi: 10.1056/NEJMoa1507062 – volume: 18 start-page: 68 year: 2018 ident: 2021110300161443800_CIT0010 article-title: Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(17)30474-7 – volume: 68 start-page: 77 year: 2018 ident: 2021110300161443800_CIT0018 article-title: Absence of cerebrospinal fluid pleocytosis in tuberculous meningitis is a common occurrence in HIV co-infection and a predictor of poor outcomes publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2018.01.014 – volume: 119 start-page: 101864 year: 2019 ident: 2021110300161443800_CIT0012 article-title: Comparison of the Mycobacterium tuberculosis molecular bacterial load assay, microscopy and GeneXpert versus liquid culture for viable bacterial load quantification before and after starting pulmonary tuberculosis treatment publication-title: Tuberculosis (Edinb) doi: 10.1016/j.tube.2019.101864 – volume: 215 start-page: 1020 year: 2017 ident: 2021110300161443800_CIT0016 article-title: Leukotriene A4 hydrolase genotype and HIV infection influence intracerebral inflammation and survival from tuberculous meningitis publication-title: J Infect Dis doi: 10.1093/infdis/jix050 – volume: 3 start-page: e1772 year: 2008 ident: 2021110300161443800_CIT0017 article-title: Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults publication-title: PLoS One doi: 10.1371/journal.pone.0001772 – ident: 2021110300161443800_CIT0009 |
SSID | ssj0011805 |
Score | 2.4187927 |
Snippet | Abstract
Background
The World Health Organization recommends GeneXpert MTB/RIF Ultra (Xpert Ultra), a fully automated polymerase chain reaction (PCR) assay, as... The World Health Organization recommends GeneXpert MTB/RIF Ultra (Xpert Ultra), a fully automated polymerase chain reaction (PCR) assay, as the initial... High cerebrospinal fluid (CSF) tuberculosis bacillary load, as measured by GeneXpert Ultra cycle threshold tertile, is associated with an almost 2-fold higher... |
SourceID | pubmedcentral proquest crossref oup |
SourceType | Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
StartPage | e3505 |
SubjectTerms | Online only |
Title | Cerebrospinal Fluid Bacillary Load by Xpert MTB/RIF Ultra Polymerase Chain Reaction Cycle Threshold Value Predicts 2-Week Mortality in Human Immunodeficiency Virus–Associated Tuberculous Meningitis |
URI | https://www.proquest.com/docview/2447316413 https://pubmed.ncbi.nlm.nih.gov/PMC8563165 |
Volume | 73 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3NjpRAEO6YPRgvxt84rrspEz0ZsgPdMHDcnTjZUdHNhtnMjfQfWRICG34Oc_MdfCjfwyexCpiJGM2eqe4mfA310VX1FWPvlBC-z_2FEwVKOyL0rYOWrsO5VJ7SNjR93Vr8NbjciE9bfzuKJDX_COFH_EwjKnifEqk_6X6i_yWN_OTb9hAtcMM-VRGpQn84Fo4J7n8PnrieSTkbscppTuQfTmb1hD0e2SGcD3A-ZQ9s-Yw9jMf493P2c2lr_ImlXh9ktyq63MCF1NQ6qN7Bl0oaUDvY3tm6hTi5OLter2BT4FJwVRU7OoBqLCxvZV7CtR1qGmC5w7UgQVAbikXBjSw6C1c1rdo24Dmk6Atxz9ORswOO7Y_-YU21JZWxJEJBFZxwk9dd8-v7jz3m1kDSKVvrrqi6BmI7tEfKmxdss_qYLC-dsRWDo4UftY6xGnkVDxBWfyFdz6rIlXPD5VwLoT2N3wFlgkgKkbk6ijKTcde6YSQy4Uqt5vwlOyqr0r5iEHKtAoW8xTUUdUSGmoVRsEBaJAOcMJyxD3uUUj3qlFO7jCId4uU8pWbDe0xn7P3B-m7Q5_iPHSDg95i83e-GFN8xCpzI0uLjSZECUYMv9Pcztphsk8OEpNI9vVLmt71ad-gHONZ_ff8NHLNHHmXM0KG194YdtXVnT5DytOoUyf7682m_638Dc40GAQ |
linkProvider | Oxford University Press |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cerebrospinal+Fluid+Bacillary+Load+by+Xpert+MTB%2FRIF+Ultra+Polymerase+Chain+Reaction+Cycle+Threshold+Value+Predicts+2-Week+Mortality+in+Human+Immunodeficiency+Virus-Associated+Tuberculous+Meningitis&rft.jtitle=Clinical+infectious+diseases&rft.au=Martyn%2C+Emily+M&rft.au=Bangdiwala%2C+Ananta+S&rft.au=Kagimu%2C+Enock&rft.au=Rutakingirwa%2C+Morris+K&rft.date=2021-11-02&rft.issn=1537-6591&rft.eissn=1537-6591&rft.volume=73&rft.issue=9&rft.spage=e3505&rft_id=info:doi/10.1093%2Fcid%2Fciaa1444&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1058-4838&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1058-4838&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1058-4838&client=summon |